Sign InBreakout Stocks of Week 16 @ SIX
NASDAQ was up by impressive 6.84% last week (week 15) ending at 24,468.48 points points after ending the week prior at 22,902.89 points. Normally this would indicate a weaker week ahead of us. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Swiss Re AG SIX:SREN. This stock has had a buy signal since Apr 17, 2026 when the price was 131.55 Fr , but have so far fallen 0% to 131.55 Fr. Some other companies are on our watchlist to, among these are Novartis AG SIX:NOVN Allreal Holding AG SIX:ALLN Swiss Prime Site AG SIX:SPSN and PSP Swiss Property AG SIX:PSPN which all got a breakout pattern emerging.
| Date | Company | Price | Week 16 |
|---|---|---|---|
| Swiss Re Ag | 131.55 Fr | 128.40 Fr | -2.39% |
| Novartis Ag | 118.82 Fr | 113.70 Fr | -4.31% |
| Allreal Holding Ag | 221.00 Fr | 218.00 Fr | -1.36% |
| Swiss Prime Site Ag | 136.80 Fr | 136.30 Fr | -0.365% |
| Psp Swiss Property Ag | 157.90 Fr | 157.80 Fr | -0.0633% |
The Swiss Re AG stock price gained 0.80% on the last trading day (Friday, 17th Apr 2026), rising from 130.50 Fr to 131.55 Fr. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 1.38% from a day low at 130.10 Fr to a day high of 131.90 Fr. The price has risen in 7 of the last 10 days but is still down by -0.19% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 246 thousand more shares were traded than the day before. In total, 907 thousand shares were bought and sold for approximately 119.27 Fr million.
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Swiss Re AG stock to perform well in the short-term.
About Swiss Re AG:
Swiss Re AG, together with its subsidiaries, provides wholesale reinsurance, insurance, other insurance-based forms of risk transfer, and other insurance-related services worldwide. The company operates through Property & Casualty Reinsurance, Life & Health Reinsurance, and Corporate Solutions. The Property & Casualty Reinsurance segment underwrites property reinsurance, including property, credit and surety, engineering, aviation, marine, agriculture, retakaful, and facultative reinsurance solutions; and casualty reinsurance, such as liability, motor, worker's compensation, personal accident, management and professional liability, cyber, and facultative reinsurance solutions. The Life & Health Reinsurance segment underwrites life and health insurance products. The Corporate Solutions segment offers standard risk transfer covers and multi-line programs to customized solutions. It serves stock and mutual insurance companies, public sector and governmental entities, mid-sized and large corporations, and individuals. Swiss Re AG was founded in 1863 and is headquartered in Zurich, Switzerland.
The Novartis AG stock price gained 1.19% on the last trading day (Friday, 17th Apr 2026), rising from 117.42 Fr to 118.82 Fr. During the last trading day the stock fluctuated 1.43% from a day low at 117.14 Fr to a day high of 118.82 Fr. The price has fallen in 6 of the last 10 days and is down by -3.32% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 780 thousand more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately 360.52 Fr million.
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Novartis AG stock to perform well in the short-term period.
About Novartis AG:
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
The Allreal Holding AG stock price fell by -1.12% on the last day (Friday, 17th Apr 2026) from 223.50 Fr to 221.00 Fr. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 2.28% from a day low at 219.50 Fr to a day high of 224.50 Fr. The price has fallen in 6 of the last 10 days and is down by -3.07% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -6 thousand shares and in total, 44 thousand shares were bought and sold for approximately 9.78 Fr million.
Allreal Holding AG holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About Allreal Holding AG:
Allreal Holding AG, through its subsidiaries, operates as a real estate company in Switzerland. It operates through two divisions, Real Estate and Projects & Development. The Real Estate division invests in residential and commercial properties. This division also provides various real estate services, such as portfolio management, and real estate and building management. The Projects & Development division provides project development, real estate consultancy, and contract administration services. This division engages in the development, realization, purchase, and sale of real estate. Allreal Holding AG was founded in 1999 and is based in Baar, Switzerland.
The Swiss Prime Site AG stock price fell by -0.364% on the last day (Friday, 17th Apr 2026) from 137.30 Fr to 136.80 Fr. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 1.69% from a day low at 135.70 Fr to a day high of 138.00 Fr. The price has fallen in 6 of the last 10 days and is down by -0.07% for this period. Volume has increased on the last day by 53 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 168 thousand shares were bought and sold for approximately 23.05 Fr million.
The Swiss Prime Site AG stock holds several negative signals and despite the positive trend, we believe Swiss Prime Site AG will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
About Swiss Prime Site AG:
Swiss Prime Site AG, a real estate company, engages in buying and selling, managing, and developing investment properties in Switzerland. The company operates in two segments, Real Estate and Services. The Real Estate segment purchases, sells, leases, and develops properties. The Services segment engages in the real estate related service and retail and asset management business. Swiss Prime Site AG was founded in 1999 and is headquartered in Olten, Switzerland.
The PSP Swiss Property AG stock price fell by -0.567% on the last day (Friday, 17th Apr 2026) from 158.80 Fr to 157.90 Fr. During the last trading day the stock fluctuated 1.72% from a day low at 156.80 Fr to a day high of 159.50 Fr. The price has been going up and down for this period, and there has been a -1.86% loss for the last 2 weeks. Volume has increased on the last day by 36 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 96 thousand shares were bought and sold for approximately 15.18 Fr million.
The PSP Swiss Property AG stock holds several negative signals and despite the positive trend, we believe PSP Swiss Property AG will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
About PSP Swiss Property AG:
PSP Swiss Property AG, together with its subsidiaries, owns and operates real estate properties in Switzerland. It operates through Real Estate Investments and Property Management segments. The company owns, operates, and leases office, retail, gastronomy, and parking spaces. It owns 158 office and commercial properties, and 18 development sites and individual projects in Zurich, Geneva, Basel, Bern, and Lausanne. The company was founded in 1999 and is based in Zug, Switzerland.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
